Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

1.50
Delayed Data
As of Jul 22
 +0.02 / +1.35%
Today’s Change
1.08
Today|||52-Week Range
3.33
-8.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash9.4M10.5M29.1M25.9M
 
 
 
 
 
Short Term Investment Cash3.0M1.1M18.6M-3.3M
 
 
 
 
 
Cash & Short Term Investments9.4M10.5M29.1M25.9M
 
 
 
 
 
 
ReceivablesReceivables0.00----0.00--
 
InventoriesInventories0.00----0.00--
 
Current AssetsPrepaid Expenses153.0K------
 
 
Other Current Assets0.00198.0K527.0K548.0K
 
 
 
 
Current Assets9.5M10.7M29.7M26.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross74.0K74.0K74.0K74.0K
 
 
 
 
 
Depreciation-66.0K-71.0K-73.0K-74.0K
 
 
 
 
 
Intangible Assets30.0K23.0K15.0K8.0K
 
 
 
 
 
Other Assets30.0K23.0K15.0K8.0K
 
 
 
 
 
Total Assets9.6M10.7M29.7M26.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable397.0K762.0K0.000.00
 
 
 
Accrued Expenses1.1M1.1M125.0K219.0K
 
 
 
 
 
Other Current Liabilities1.1M1.1M1.0M667.0K
 
 
 
 
 
Other Liabilities1.6M2.5M1.7M1.4M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities6.0K0.000.000.00
 
 
Total Liabilities1.6M2.5M1.7M1.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock7.4M7.3M7.3M7.6M
 
 
 
 
 
Common Equity533.0K894.0K20.6M17.5M
 
 
 
 
 
Total Shareholder Equity7.9M8.2M28.0M25.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding16.1M18.4M22.3M28.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.